TF
WVE icon

TimeScale Financial’s Wave Life Sciences WVE Stock Holding History

TimeScale Financial’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-166
Closed -$3K – 555
2019
Q3 		$3K Hold
166
– – ﹤0.01% 431
2019
Q2 		$4K Buy
+166
New +$4.66K ﹤0.01% 439

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TimeScale Financial's WVE Position: Q4 2019 in Review

TimeScale Financial sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 166 shares — an estimated $3K sold.

TimeScale Financial first reported a position in WVE in Q2 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • TimeScale Financial reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • TimeScale Financial sold 166 Wave Life Sciences shares in Q4 2019, an estimated $3K.
  • TimeScale Financial first reported a position in Wave Life Sciences in Q2 2019 and held it in 2 quarters.
  • TimeScale Financial's Wave Life Sciences position peaked at $4K in Q2 2019.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on TimeScale Financial's 13F filing for Q4 2019, filed 28 Jan 2020.